Skip to content
  • Tuesday, 25 August 2026
  • 1:09 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • CEO of CDMO AustinPx on its exclusive agreement with Thermo Fisher’s Patheon division
Laboratory Automation & Robotics

CEO of CDMO AustinPx on its exclusive agreement with Thermo Fisher’s Patheon division

Lana Keisha Jul 18, 2026 0

AustinPx, a Contract Development and Manufacturing Organization (CDMO) based in Texas, has forged an exclusive agreement with Thermo Fisher Scientific’s…

Read More
Laboratory Automation & Robotics

CEO of CDMO AustinPx on its exclusive agreement with Thermo Fisher’s Patheon division

Lana Keisha Jul 10, 2026 0

AustinPx, a Texas-based Contract Development and Manufacturing Organization (CDMO) specializing in bioavailability enhancement, has forged an exclusive agreement with Thermo…

Read More
Moderate Consumption of Caffeinated Coffee and Tea Associated with Reduced Risk of Dementia and Slower Cognitive Decline Over Four DecadesArtificial Intelligence Systems Struggle with Cognitive Focus and Distraction Management in New Research StudyImmuto Scientific Pioneers AI-Enhanced Mass Spectrometry for Unprecedented Protein Structure ThroughputChiral Phonons Breakthrough Paves Way for Highly Efficient Orbitronic Computing Devices Using Sustainable Materials
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ